HKSE - Delayed Quote HKD

JD Health International Inc. (6618.HK)

38.950
-1.000
(-2.50%)
At close: 4:08:33 PM GMT+8

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Enlin Jin CEO & Executive Director 2.49M -- 1981
Ms. Deng Hui Chief Financial Officer -- -- 1987
Mr. Ming King Chiu FCIS, FCS Company Secretary -- -- 1977

JD Health International Inc.

Jingdong Headquarters
Block C, Building 2 No. 20 Kechuang 11 Street, Daxing District Yizhuang Economic and Technological Development Zo
Beijing, 101111
China
https://ir.jdhealth.com
Sector: 
Healthcare
Full Time Employees: 
3,564

Description

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Corporate Governance

JD Health International Inc.’s ISS Governance QualityScore as of May 1, 2025 is 10. The pillar scores are Audit: 4; Board: 2; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 13, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC

JD Health International Inc. Earnings Date

Recent Events

Related Tickers